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Abstract 
Ciprofloxacin (CfH, C17H18FN3O3) crystallizes with 2-thiobarbituric (H2tba) and barbituric acid 
(H2ba) in the aqueous solution to yield salt CfH2(Htba)∙3H2O (1), salt co-crystal 
CfH2(Hba)(H2ba)∙3H2O (2) and salt CfH2(Hba)∙H2O   (3). The compounds are structurally 
characterized by the X-ray single-crystal diffraction. The numerous intermolecular hydrogen 
bonds N—H∙∙∙O and O—H∙∙∙O, forming of water molecules, Htba−/Hba− and CfH2+ ions, and 
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H2ba molecules stabilize the crystal structures of 1-3. Hydrogen bonds form a 2D plane network 
in the salts of 1 and 3, and a 3D network in the salt co-crystal of 2. There are different π−π 
interactions in 1-3. The compounds have been characterized by powder XRD, TG-DSC and FT-
IR. The compounds dehydration ends at 130-150 °C, and their oxidative decomposition is 
observed in the range of 250-275 °C.  
 
Keywords: Thiobarbituric acid; barbituric acid; ciprofloxacin; salts; salt co-crystal; X-ray 
diffraction; infrared spectroscopy; thermal stability 
 
1. Introduction 
Fluoroquinolones are one of the most important classes of synthetic antibiotics [1]. 
However, the molecular mechanism of this enzyme inhibition is still unknown [2, 3]. 
Ciprofloxacin (CfH), 1-Cyclopropyl-6-fluoro-4-oxo-7(piperazin-1-yl)-1,4-dihydro-3-
quinolinecarboxylic acid (Fig. 1a) is a widely prescribed broad-spectrum oral fluroquinolone 
antibiotic [4]. It forms different unstable hydrates [5]. In the aqueous solution, CfH exists 
predominantly as a zwitterion (isoelectric point = 7.42). Its intrinsic solubility in water at 25 °C 
is comparatively low ca. 0.08 g∙l−1 [6]. One obvious way to increase the aqueous solubility of 
CfH is to make a salt [7]. The most common marketed form of CfH is that of the hydrochloride 
monohydrate. Evidently, a further search for other ciprofloxacin salts with improved properties 
is of great practical interest in pharmacology [8, 9]. Along with the salts, it is possible to use the 
so-called salt co-crystals [10, 11] (or ionic co-crystals, ICCs [12]). The term “salt co-crystal” 
indicates that a salt, be it inorganic and organic, can co-crystallize with an organic molecule [11].  
In a co-crystal, if at least one of coformers is a drug molecule or ion, then it is termed as a 
pharmaceutical co-crystal [13]. Today, the discovery and exploration of pharmaceutical co-
crystals and salts present a major perspective for the controlled modification of key 
pharmaceutical properties, such as solubility, hydroscopicity, physicochemical stability, 
photostability and dissolution performance [14]. 
Barbituric (H2ba) and thiobarbituric (H2tba) acids (Fig. 1b) are the lead structures of 5,5-
substituted barbiturates and thiobarbiturates, respectively, and they are important groups of 
sedative/hypnotic drugs [15]. The Hba  and Htba anions are exceptionally good hydrogen 
bonding acceptors and donors, which is important for the crystal design of pharmaceuticals and 
molecular recognition [16]. They can be linked by intermolecular hydrogen bonds to other 
complementary neutral molecules, for example, such as H2ba and H2tba, to form salt co-crystals 
[10, 17, 18]. Thus, salt co-crystals M(Hba)(H2ba)∙2H2O (M = Na, K), K(Hba)(H2ba)0.5∙1.5H2O 
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[10] and Rb(Hba)(H2ba)∙H2O [17] were previously synthesized. The formation of co-crystals 
leads to an increase of the H2ba thermal stability [10]. In the present work, for the first time [19], 
the structures of compounds formed by fluoroquinolones and barbituric/thiobarbituric acids were 
solved.  The fundamental aim of the present work is to evaluate the solid-state of these 
compounds. The ciprofloxacinium thiobarbiturate trihydrate, CfH2(Htba)∙3H2O (1), 
ciprofloxacinium 2-thiobarbiturate 2-thiobarbituric acid trihydrate, CfH2(Hba)(H2ba)∙3H2O  (2) 
and ciprofloxacinium barbiturate monohydrate, CfH2(Hba)∙H2O   (3) are synthesized and 
structurally characterized by the X-ray single-crystal diffraction. Besides, the spectroscopic and 
thermal properties of 1-3 were observed. 
2. Experimental section 
2.1. Chemical reagents 
Barbituric acid (CAS 67-52-7) and 2-thiobarbituric acid (CAS 504-17-6) were purchased 
from Sigma-Aldrich and used without further purification. Ciprofloxacinium chloride 
monohydrate (CfH·HCl·H2O, Ranbaxia, India) was used without further purification.  
 
2.2. Synthesis 
0.2 g (0.5 mmol) of ciprofloxacin hydrochloride monohydrate was dissolved in 5 ml of 
water, then 0.074 g (0.5 mmol) H2tba and 0.02 g (0.5 mmol) NaOH were added. The resulting 
mixture was heated to 80°C and held at this temperature for 30 min. The pale yellow bulk 
precipitate formed in the solution was filtered off and discarded as it consists of a mixture of 
several phases. The hot filtrate (pH 4) was cooled to room temperature and held at 3°C for two 
days. The formed pale yellow crystal precipitate of CfH2(Htba)∙3H2O (1) was filtered, washed 
with water (1 ml), acetone and dried in the air (yield 30 %). 
The synthesis of CfH2(Hba)·H2O (3) was performed similar to the synthesis of 1, except for 
an equimolar amount of H2ba (0.064 g, 0.5 mmol) used instead of H2tba. After dissolving all the 
reagents at 80°C, the solution was slowly cooled to room temperature (pH 4.6) and, then, the 
resulting colourless crystalline precipitate was filtered off, washed with water (1 ml), acetone 
and air-dried (yield 58%).  
Compound CfH2(Hba)(H2ba)∙3H2O (2) was obtained under similar conditions, except for 
that the double excess of H2ba (0.128 g, 1.0 mmol) was used. After dissolving all the reagents at 
80°C, the solution was slowly cooled to room temperature (pH 4.0) and then stored at 2°C for 24 
h. The resulting pale yellow crystalline precipitate was filtered off, washed with water (1 ml), 
acetone and air-dried (yield 60%).  
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The elemental analysis for C21H28FN5O8S (1): Calc.: C, 47.6%; H, 5.33%; N, 13.2%; S, 
6.06. Found: C, 47.2%; H, 5.52%; N, 12.9%; S, 6.21%. The elemental analysis for C25H32FN7O12 
(2): Calc.: C, 46.8%; H, 5.03%; N, 15.3%. Found: C, 46.2%; H, 5.22%; N, 15.0%. The elemental 
analysis for C21H24FN5O7 (3): Calc.: C, 52.8%; H, 5.07%; N, 14.7%. Found: C, 52.2%; H, 
5.24%; N, 14.5%. 
The single crystals suitable for a structural analysis were selected directly from the total 
mass of precipitates 1-3. The powder patterns of 1-3, simulated from the single crystal structural 
data, well agree to the measured ones (Figs. 1S, 2S, 3S) indicating that the corresponding crystal 
structures represent the bulk structures. 
 
2.2. X-ray diffraction analysis 
The intensity patterns were collected from single crystals 1-3 using the SMART APEX II 
diffractometer (Bruker AXS) equipped with a CCD-detector, graphite monochromator and Mo-
Kα radiation source. The absorption corrections were applied using the SADABS program. The 
structures were solved by the direct methods using package SHELXS and refined in the 
anisotropic approach for non-hydrogen atoms using the SHELXL program [20]. All hydrogen 
atoms were found via Fourier difference maps. Further, the hydrogen atoms which are linked 
with C,N atoms in the Htba– and CfH2
+ ions in 1 and 2 were positioned geometrically as riding 
on their parent atoms with d(C–H) = 0.93-0.98 Å, d(N–H)=0.86-0.89 Å depending on the 
geometry and Uiso(H) = 1.2Ueq(C,N). All hydrogen atoms of the H2O molecules and one H atom 
in the OH group of CfH2
+ ion were refined with bond length restraint d(O–H)=0.9 Å and Uiso(H) 
= 1.2Ueq(O). The structure test for the presence of missing symmetry elements and possible 
voids was produced using program PLATON [21]. The DIAMOND program is used for the 
crystal structure plotting [22]. 
The powder X-ray diffraction data were obtained using diffractometer D8 ADVANCE 
(Bruker) equipped by a VANTEC detector with a Ni filter. The measurements were made using 
Cu Kα radiation. The structural parameters defined by single crystal analysis were used as a base 
in the powder pattern Rietveld refinement.  
 
2.3. Physical measurements 
TGA was carried out on the simultaneous SDT-Q600 thermal analyzer (TA Instruments, 
USA) under the dynamic air atmosphere (50 ml/min flow rate) within 25–350 °C at the scan rate 
of 10 °C/min. The qualitative composition of the evolved gases was determined by FT-IR 
spectrometer Nicolet380 (Thermo Scientific, USA) combined with a thermal analyzer and with 
the TGA/FT-IR interface (attachment for the gas phase analysis). This set up allows making a 
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simultaneous accumulation of the DTA and TG data, and the composition of the released gas 
phase. The compound weight was 6.442 mg for 1, 8.433 mg for 2 and 4.442 mg for 3. Platinum 
crucibles with perforated lids were used as the containers. The IR absorption spectra of the 
compounds inserted into the KBr tablets were recorded over the range of 400–4000 cm−1 at room 
temperature on an FT-IR spectrometer Nicolet 6700 (Thermo Scientific, USA, SFU CEJU). 
 
3. Results and discussion 
3.1. Crystal structures of 1 
The unit cell of CfH2
+(Htba−)∙3H2O corresponds to the triclinic symmetry. Space group P-1 
was determined from the statistical analysis of the reflection intensities. The main crystal data 
are shown in Table 1. The corresponding bond lengths C—O, C—S, C—N, С—С and valence 
angles in the CfH2
+ cation and Htba– anion (Table 1S) well related to those found earlier for 
other compounds [8, 9, 19, 23-31]. The independent part of the unit cell contains one CfH2
+ ion, 
one Htba– ion and three H2O molecules (Fig. 2a). There are two intramolecular hydrogen bonds 
C—H···F, O—H···O and ten intermolecular hydrogen bonds N—H···O and O—H···O in  
structure 1 (Fig. 3a, Table 2) which form the 2D plane network. This is a 5-nodal net with 
stoichiometry (3-c)(3-c)(3-c)(4-c)(5-c) and with the vertex symbol 
(4.52.62.7)(4.54.6.73.8)(5.6.7)(5.6.9)(52.7), which is new [32]. Hydrogen bonds form two 
alternating infinite chains, one of them consists of CfH2
+ ions bound by water molecules; the 
second one consists of Htba− ions and water molecules (Figure 3a). Each CfH2
+ ion in the chain 
forms H-bonds with two water molecules, while the sequence of molecules is 
CfH2
+∙∙∙H2O∙∙∙CfH2+∙∙∙H2O. When the CfH2+ ion interacts with one water molecule H2(O1W), the 
piperazin-1-yl  N atom of NH2
+ group is the H-bond donor (N1—H∙∙∙O1W), but when the CfH2+ 
ion interacts with another water molecule H2(O2W), the O2 atom is the H-bond acceptor (Н-
bond O2W—H∙∙∙O2). Htba-ions are combined together by hydrogen bonds N—H···O into pairs 
with the formation of supramolecular motif R2
2(8), which is often found in other thiobarbiturate 
compounds [23-30]. These pairs are connected together by H-bonds with the participation of two 
water molecules (cyclic motif R4
2(8)) and that results in the formation of an infinite chain. The 
interesting ring supramolecular motifs in this network are formed by the hydrogen bonds 
between ions CfH2
+ and Htba– (R5
5(14), R6
5(27)) (Fig. 3a). Also, there are π−π interactions 
between Htba− and CfH2
+ rings (Table 2S, Fig. 4Sa). CfH2
+ ions are connected in pairs by the 
π−π interaction of head-to-tail type. 
 
3.2. Crystal structure of 2  
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Compound CfH2(Hba)(H2ba)∙3H2O (2) is a pharmaceutical co-crystal [13]. The unit cell of 
CfH2(Hba)(H2ba)∙3H2O (2) also corresponds to the triclinic symmetry. Space group P-1 was 
determined from the statistical analysis of the reflection intensities. The main crystal data can be 
found in Table 1. The main bond lengths C—O, C—N, С—С and valence angles are enumerated 
in Table 1S. They coincide with those given in the literature for the CfH2
+ [8, 9, 19] and 
uncoordinated Hba− ions [33-36]. The main geometric parameters of H2ba in 2 coincided with 
those found in the free keto form H2ba [37] and co-crystals [10, 17]. The independent part of the 
unit cell contains one CfH2
+ ion, one Hba– ion (A), one H2ba (B) molecule and three H2O 
molecules (Fig. 2b). There are two intramolecular hydrogen bonds C–H···F, O–H···O and 
twelve intermolecular hydrogen bonds N—H···O, O—H···O in the structure (Fig. 3b, Table 2) 
which form a 3D network. This is a 4-nodal net with stoichiometry (3-c)(3-c)(3-c)2(5-c) and 
point symbol (4.5.6)2(5.6
2)(52.63.8.94)(6.102), which is also new  [32]. Intermolecular hydrogen 
bonds N—H...O form the chain of alternating Hba– and H2ba in the keto form based on the R2
2(8) 
pattern. In compounds Rb(Hba)(H2ba)∙3H2O [17] and M(Hba)(H2ba)∙3H2O (M = Na, K) [10],  
the chains with sequence H2ba∙∙∙Hba−∙∙∙H2ba∙∙∙Hba−.also are formed. However, in 
K(Hba)(H2ba)0.5∙1.5H2O, sequence H2ba∙∙∙Hba−∙∙∙Hba−∙∙∙H2ba is observed [10]. Salt co-crystals 
MBr∙H2ba (M = Rb, Cs) and CsI∙H2ba are characterized by the presence of H2ba dimers linked 
via N—H···O hydrogen bonds [38]. Dimeric fragment H2tba∙∙∙Htba− was observed in the salt co-
crystal of piperidinium (PipeH+) 2-thiobarbiturate and 2-thiobarbituric acid, PipeH(Htba)H2tba 
[18]. In 2, two water molecules joint CfH2
+ ions in pairs by hydrogen bonds O—H···O forming a 
16-membered ring (R6
4(16)). Hydrogen bonds OW—H···OW’ atract four water molecules (motif 
R4
4(8)) in the cycle, three of which are bound by hydrogen bonds OW—H∙∙∙O3A with three Hba- 
(A) ions, forming two bound infinite chains ∙∙∙Hba−∙∙∙H2ba∙∙∙Hba−∙∙∙H2ba∙∙∙ (Fig. 3b). CfH2+ ions 
are also combined into pairs by intermolecular hydrogen bonds OW—H...O with the 
participation of just two water molecules. Each CfH2
+ ion is bound to Hba or H2ba by a single 
hydrogen bond N1—H···O (Table 2). The hydrogen bonds involving Hba– ions, H2ba and H2O 
molecules also form other cyclic motifs in this network R4
4(8), R5
4(14) and R6
6(20) (Fig. 3b). 
There are π-π interactions between Hba− and CfH2+ rings in 2. Like in 1, two CfH2+ form the 
pairs in 2 (Table 2S, Fig. 4Sb). 
 
3.3. Crystal structure of (3) and comparison 
The unit cell of CfH2(Hba)∙H2O (3) corresponds to the monoclinic symmetry. Space group 
P21/c was determined from the extinction rules and statistical analysis of the reflection 
intensities. The main crystal data are summarized in Table 1. The main defined bond lengths and 
valence angles are shown in Table 1S. They relate well to those found in 2 and in the literature 
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for the CfH2
+ [8, 9, 19] and Htba− ions [33-36]. The independent part of the unit cell contains one 
CfH+ ion, one Hba– ion and one H2O molecule (Fig. 2c). There are two intramolecular hydrogen 
bonds C–H···F, O–H···O and five intermolecular hydrogen bonds N–H···O, O–H···O in the 
structure (Fig. 3c, Table 2), which form a 2D network. 
Hba– ions are connected to each other by two hydrogen bonds N—H···O, closing the 8-
membered ring (R2
2(8)). As a result, they form their infinite chains along the a-axis. With the 
help of H-bonds N1—H···O and O—H···O, these infinite chains of Hba– ions are joined together 
by other chains containing one ion CfH2
+, H2O and Hba
−. The H-bond donor is the positively 
charged piperazinium N1 atom in CfH2
+, which directly joints CfH2
+ and Hba− using H-bond 
N1—H···O2A. The acceptor O3 atom of CfH2
+ carboxyl group is attracted by Н-bond O1W—
H11W···O3 with the water molecule, which simultaneously forms H-bond O1W—H11W···O3A 
with Hba−. This is a 2-nodal net with stoichiometry (2-c)2(4-c) and point symbol (6.10
5)(6)2, 
which is also new  [32]. There are two most interesting motifs in this network: R2
2(8) and 
R10
9(52) (Fig. 3c). Also, there are π-π interactions between the two rings of CfH2+ (Table 2S, Fig. 
4S). 
It is possible to point out the similarity in the structure of the compounds under study. Water 
molecules stabilize crystal structures 1-3 by forming a diverse arrangement of supramolecular 
heterosynthons (Fig. 3). There are two intramolecular hydrogen bonds C—H···F, O—H···O in 1-
3 (Fig. 2). The carbonyl and carboxyl groups of CfH2
+ are involved in a strong intramolecular 
O3—H⋯O1 hydrogen bond and, therefore, the O3—H group does not participate in the 
formation of intermolecular hydrogen bonds. This limits the possibility of fluoroquinolones self-
association, for example, in 1-3, CfH2
+ cations are not directly related to each other. In 2 and 3, 
the CfH2
+ ions are bound to Hba or H2ba by hydrogen bond N1—H...O (Table 2), but in 1, CfH2
+ 
ions are bound to Htba– through bridging water molecules. Compounds 1-3 possess very similar 
bond lengths O—C, C4—C5, and C5—C6 in the О=С4−С5Н−С6=О group (Fig. 2, Table 1S), 
and that indicates the formation of the Hba– and Htba– anions accompanied by the charge 
delocalization. Earlier, such delocalization was observed in other 2-thiobarbiturates [23-31] and 
1,3-diethyl-2-thiobarbiturates [39-43]. Structures 1-3 are stabilized by ππ interactions between 
CfH2
+ ions of the head-to-tail type. These interactions connect CfH2
+ ions in pairs in structures 1-
3 (Table 2S, Fig. 4S). Also, there are π-π interactions between Htba−/Hba− and CfH2+ ions in 1-2. 
 
3.3. Theoretical consideration 
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It is generally accepted that the reaction of an acid (in our case H2tba and H2ba) with a base 
(CfH) is expected to form a salt if ΔpKa= pKa(base) − pKa(acid) > 2 or 3 [44]. In spite of that the 
pKa value describes equilibrium phenomena in the solution, it remains to be a useful method for 
the prediction of the ionization state in crystals [ 44]. 
 
CfH2
+ ↔ CfH + H+   pKa= 6.05 [45] 
H2tba ↔ Htba− + H+   pKa= 1.87 [46],    
H2ba ↔ Htba− + H+   pKa= 4.03 [47] 
 
For reaction H2tba + CfH ↔ Htba− + CfH2+  
Keq =  [Htba
−] [CfH2
+]/ [H2tba] [CfH] = 10
6.05 / 101.87 = 104.18  ≈ 1.51∙104.   
 
Therefore, the concentration of ionized species will be 1.51∙104 times greater that the 
concentration of non-ionized species in an aqueous solution, containing the equimolar amounts 
of CfH and H2tba. The salt formation of 1 is consistent with the ΔpKa rule. 
 
For reaction H2ba + CfH ↔ Hba− + CfH2+  
Keq =  [Hba
−] [CfH2
+]/ [H2ba] [CfH] = 10
6.05 / 104.03 = 102.02 ≈ 105. 
 
In the aqueous solution, containing the equimolar amounts of CfH and H2ba, the ΔpKa value for 
the interaction between CfH2
+ and H2ba is 2.02 which is also preferable for the formation of salt 
3. However, at molar ratio CfH:H2ba = 1:2 (pH 4), the ionized and non-ionized H2ba species are 
coexisted in approximately equal concentrations. Thus, a favorable condition appears for the 
crystallization of phase 2, containing H2ba molecules and Hba
– anions together. The C—O 
distances (d(O1A—C2A) = 1.235(2) Å, d(O2A—C4A) = 1.265(2) Å, d(O3A—C6A) = 1.265(2) 
Å in the Hba− ion (A) (Table 1S)  are greater than the C—O distances in the un-ionized trioxo 
form of H2ba [37]. The C—O distances (d(O1B—C2B) = 1.218(2) Å, d(O2B—C4B) = 1.230(2) 
Å, d(O3B—C6B) = 1.206(2) Å in the H2ba (B) molecule coincide with the distances of C—O in 
the molecular trioxo form of H2ba. A similar difference between the lengths of the С—О bonds 
in the Hba– ion and the H2ba molecule was found in other salt co-crystals. For example, d(O—C) 
of H2ba in salt co-crystals Rb(Hba)(H2ba)∙3H2O [17], M(Hba)(H2ba)∙3H2O (M = Na, K), 
K(Hba)(H2ba)0.5∙1.5H2O [10], MBr∙H2ba (M =Rb, Cs) and CsI∙H2ba [38] are in the range of 
1.21-1.22 Å, but these values of Hba− are bigger and they are in the range of 1.23-1.27 Å. The 
distances O—C in the trioxo form of detached H2ba (1.21−1.22 Å) [37] are similar to those in the 
above mentioned co-crystals and compounds [Ca(μ3-H2ba−O,O’,O’’)]X2 (X = Cl [12], I [48]).  
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The equilibrium equation for solubility 2 has the form: 
 
CfH2(Hba)(H2ba)∙3H2O↔ CfH2+ + Hba− + H2ba + 3H2O 
 
The concentration of water can be considered as almost constant and, at pH 4, ciprofloxacin 
exists almost completely in the form of a CfH2
+ cation [45]. Therefore, the minimal solubility of 
2 corresponds to the maximal value of the product of equilibrium concentrations [Hba−]∙[H2ba] 
in the aqueous solution. It is easy to show that the minimal solubility should be observed under 
the condition of [Hba−] = [H2ba] and at рН = pKa ≈ 4. Such equilibrium pH value was 
established immediately after the completion of crystallization 2 from the aqueous solution 
containing stoichiometric amounts of CfH·HCl·H2O, H2ba and NaOH (Section 2.2).  
 
3.4 IR spectroscopy 
 
In good agreement, FTIR patterns of 1-3 display the characteristic absorption bands of CfH and 
barbituric/thiobarbituric acid, showing their multicomponent crystalline composition (Fig. 5S). 
For all compounds, the resulting spectra are different from the superimposed spectra of the 
starting materials. These changes point out to a different set of extended hydrogen bonding 
interactions for the carbonyl, hydroxyl and amino groups present in the crystal structures. In the 
region of stretching vibrations υ(СOOH), υ(С=O), υ(NH) and υ(NH+), IR spectra contain a large 
number of bands which complicate their assignment [7]. Thus, the assignment of the IR 
vibrational bands to the corresponding normal modes is based on [49-51]. The very broad bands 
in the 3600-3400 cm−1 region can be assigned to the stretching modes of NH and OH groups in 
CfH2
+, Htba– and Hba– ions. The absorption bands at 1709 cm–1 for 1, 1679 cm−1 for 2 and 1686 
cm−1 for 3 are attributed to the ν (COOH) vibrations in the CfH2+ cation [9, 51]. The NH group of 
the piperazine ring was protonated in the crystalline compounds, and it is represented by the 
occurrence of medium intensity bands in the 2400−2700 cm−1 region [9]. These data suggest the 
salt formation by a proton transfer from the barbituric/thiobarbituric acid to CfH. In the IR 
spectra of H2ba, the highest frequency band at 1752 cm
−1 is associated with the 4,6-CO 
symmetric vibration νs(C=O) [36, 50]. In the IR spectra of 2, it is observed at 1722 cm−1, which 
agrees with the presence of the neutral H2ba molecule, i.e. with the formation of a salt co-crystal. 
Therefore, infrared spectroscopy gave the evidence of the salt formation in 1, 3 and the salt co-
crystal formation in 2. 
 
3.5. Thermal decomposition 
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The thermal decomposition of 1 starts at ~55 °С by a loss of crystal water molecules, and it is  
accompanied by the endoeffect at 92.6 °С (Fig. 6S). The water removal is confirmed by the IR 
spectroscopic analysis of released gases. In the range from ~150 °С to ~270 °С, the sample mass 
is nearly persistent, and the mass lost (m) at 150 °С (9.2%) almost coincides with that 
calculated at the assumption of three water molecules release (10.2%). The average value of the 
CfH melting temperature is equal to 270.0 °С [52, 53], and H2tba melts with the decomposition 
at 250.6 ºC [54]. Thus, compound 1 is thermally more stable than H2tba. The melting 
accompanied by the oxidation of 1 occurred at T>270 °С, and the mass of the sample decreased 
rapidly in accordance to the mean TG curve. These transformations are accompanied by the 
endoeffect at 288.2 °C and mild exo-effect above 325 °С. According to the IR spectroscopic 
analysis of the gases evolved during thermolysis, H2O, CO2 , NH3 and SO2 are formed.  
In 2, the crystal water loss starts at ~50 °С and it is accompanied by the endoeffects at 70.2 
°С and 101.3 °С (Fig. 7S). Over the range from ~150 °С to ~250 °С, the mass of the sample is 
practically unchanged, and the mass lost (m) at 150 °С (7.6%) almost coincides with that 
calculated assuming the three water molecules release (8.4%). The sample 2 melting is 
accompanied by the oxidation occurred at T>250 °С, and the sample mass decreased rapidly at 
T>275 °С according to the mean TG curve. H2ba melts with the decomposition at 245.0 ºC [10], 
i.e. compound 2 is more thermally stable than H2ba. The oxidative decomposition of anhydrous 
organic residue is accompanied by a weak endo effect at 288.2 °C, strong exo-effect at 331.3 °С  
and emission of gaseous CO2, H2O and NH3. 
Both TG and DSC curves of 3 indicated one-step dehydration which is accompanied by the 
endo effect at 100.7 ºC (Fig. 8S). This is confirmed by the results of evolved gases IR 
spectroscopic analysis. The dehydration stage in the range of 70-130 ºC showed the weight loss 
(Δm) equal to 2.9%, but this value is lower than the calculated weight loss estimated under the 
assumption of total dehydration (−Н2О, Δmtheor=3.6%). The underestimated Δm values for 
dehydration 1-3 are probably related to the samples partial dehydration in the air. The 
dehydration of 3 is accompanied by the endoeffect at 100.7 ºC. According to TG curves, the 
mass of sample 3 remains unchanged up to ~275 ºC (Fig. 8S) and, then, it follows by oxidative 
decomposition with the gaseous  H2O, CO2, NH3 emissions. Similarly to 2, compound 3 is more 
thermal stable than H2ba. 
Thus, the TG-DSC data confirm that compounds 1-3 are hydrates and the water contents 
approximately correspond to the established chemical compositions. 
 
4. Conclusions 
 11 
 
11 
CfH crystallization with 2-thiobarbituric and barbituric acids resulted in the isolation of a 
new salt co-crystal (2) and two salts (1,3). The salt co-crystal is obtained in the region where the 
concentrations of ionized and nonionized H2ba species are close so that both species can 
crystallize out. There are two intramolecular hydrogen bonds C–H∙∙∙F, O–H∙∙∙O (Fig. 2) and 
numerous intermolecular hydrogen bonds N–H∙∙∙O, O–H∙∙∙O in the structures of 1-3 (Fig. 3, 
Table 2). The dominant hydrogen bonding is the N−H∙∙∙O interaction, which leads to a 
centrosymmetric synthon R2
2(8) and the formation of Htba− pairs in 1 and the infinite chains of 
Hba− ions in 2-3. The ciprofloxacinium cation has six potentially strong hydrogen bond acceptors 
and only two strong hydrogen bond donors (N atom in NH2
+ and O atom in COOH) (Fig. 1). 
However, the carbonyl and carboxyl groups of CfH2
+ are involved in a strong intramolecular 
hydrogen bond O3—H⋯O1 and, consequently, the O3—H group does not form a strong 
intermolecular hydrogen bond. Therefore, similar to structures 1-3, the self-association of 
fluoroquinolones with participation of O3–H group seems unlikely in other compounds. Water 
molecules stabilize crystal structures 1-3 by forming a diverse arrangement of supramolecular 
heterosynthons. The self-association of Htba−/Hba− ions and the interaction of complementary 
Hba− and H2ba also stabilize the crystal structures of 1-3 (Fig. 3). In the О=С4−С5Н−С6=О group 
of Hba– and Htba– anions, the charge delocalization is observed (Table 1S). Structures 1-3 are 
stabilized by ππ interactions between CfH2+ ions joining them in pairs (Table 2S, Figure 4S).  
 
Supplementary data 
The crystallographic data (excluding structure factors) for the structural analysis have been 
deposited with Cambridge Crystallographic Data Centre ((1) - CCDC 1544127; (2) - 
CCDC 1544128; (3) - CCDC 1544129). The information may be obtained free of charge from 
The Director, CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (Fax: +44(1223)336-033, E-
mail: deposit@ccdc.cam.ac.uk, or www: www.ccdc.cam.ac.uk). 
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Table 1. (1-3) crystal structure parameters 
Single crystal CfH2(Htba)∙3H2O (1) CfH2(Hba)(H2ba)∙3H2O (2) CfH2(Hba)∙H2O (3) 
Moiety formula C21H28FN5O8S C25H32FN7O12 C21H24FN5O7 
Dimension (mm) 0.15×0.07×0.02 0.25×0.25×0.12  0.30×0.02×0.02 
Color Pale yellow Pale yellow Colourless 
Molecular weight 529.54 641.57 477.45 
Temperature (K) 150 150 293 
Space group, Z P-1, 2 P-1, 2 P21/c, 4 
a (Å) 10.640 (2) 10.352 (2) 10.2756 (7) 
b (Å) 10.710 (2) 10.789 (2) 18.843 (2) 
c (Å) 11.476 (2) 13.440 (3) 12.049 (1) 
α (º) 68.64 (3) 72.53 (3) 90 
β (º) 78.31 (3) 82.41 (3) 113.364 (2) 
γ (º) 84.37 (3) 78.73 (3) 90 
V (Å3) 1192.2 (5) 1399.8 (6) 2141.8 (3) 
ρcalc (g/cm3) 1.475 1.522 1.481 
μ (mm-1) 0.201 0.127 0.118 
Reflections measured 13762 15702 10930 
Reflections independent 5464 6407 4378 
Reflections with F > 4σ(F) 2920 4653 1950 
2max () 55.08 55.04 52.80 
h, k, l - limits 
-13 ≤ h ≤ 13; 
-13 ≤ k ≤ 13; 
-9 ≤ l ≤ 14 
-13 ≤ h ≤ 10; 
-13 ≤ k ≤ 12; 
-17 ≤ l ≤ 17 
-10 ≤ h ≤ 12; 
-23 ≤ k ≤ 19; 
-15 ≤ l ≤ 15 
Rint 0.0773 0.033 0.065 
The weighed refinement of 
F2 
w=1/[σ2(Fo2)+(0.0472
P)2] 
w=1/[σ2(Fo2)+(0.0573P)2+
0.2036P] 
w=1/[σ2(Fo2)+(0.055
7P)2] 
No. of refinement parameters 346 427 316 
R1 [Fo > 4σ(Fo)] 0.0593 0.0433 0.0587 
wR2 0.1052 0.1046 0.1068 
Goof 0.949 1.013 0.932 
∆ρmax (e/Å3) 0.307 0.323 0.180 
∆ρmin (e/Å3) -0.340 -0.273 -0.243 
(∆/σ)max 0.001 0.002 0.000 
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Table 2. Hydrogen-bond geometry in (1-3) structures (Å, ).  
 
D—H d(D—H) d(H···A)  D—H···A D···A A Transformation for A atom 
CfH2(Htba)∙3H2O (1) 
O3—H3 0.90(3) 1.70 (3) 151 (3) 2.522 (4) O1 x, y, z 
C1—H01A 0.97 2.16 128 2.861 (4) F x, y, z 
N1—H0A 0.89 2.01 156 2.843 (3) O2W 1+x, y, z 
N1B—H1B 0.86 1.89 168 2.734 (4) O2B 2-x, 1-y, 1-z 
N1—H0B 0.89 1.95 169 2.827 (3) O1W 1-x, 1-y, 1-z 
N3B—H3B 0.86 2.42 168 3.270 (2) S 1-x, 1-y, 1-z 
O1W—H11W 0.84 (2) 2.09 (2) 169 (3) 2.918 (3) O3W 1-x, 2-y, 1-z 
O1W—H12W 0.89 (3) 1.86 (3) 166 (3) 2.728 (3) O2B 1+x, y, z 
O2W—H21W 0.91 (3) 1.91 (3) 156 (3) 2.762 (4) O2 x, -1+y, z 
O2W—H22W 0.89 (3) 1.96 (3) 168 (3) 2.834 (3) O3W 1-x, 1-y, 1-z 
O3W—H31W 0.85 (3) 2.03 (3) 156 (3) 2.829 (3) O1B 1-x, 2-y, 1-z 
O3W—H32W 0.92 (3) 1.84 (3) 171 (3) 2.756 (3) O1B x, y, z 
CfH2(Hba)(H2ba)∙3H2O (2) 
O3—H3 0.87(2) 1.70 (2) 160 (2) 2.532 (2) O1 x, y, z 
C1—H01B 0.97 2.22 125 2.894 (2) F x, y, z 
N1—H0A 0.89 1.84 172 2.727 (2) O3A 1-x, 2-y, -z 
N1—H0B 0.89 1.95 168 2.832 (2) O2B 1+x, 1+y, z 
N1A—H1A 0.86 2.10 169 2.947 (2) O1B x, y, z 
N1B—H1B 0.86 1.97 172 2.824 (2) O1A x, y, z 
N3A—H3A 0.86 2.00 175 2.860 (2) O2B 1+x, y, z 
N3B—H3B 0.86 1.91 171 2.762 (2) O2A 1-x, y, z 
O1W—H11W 0.87 (2) 1.90 (2) 173 (2) 2.764 (2) O2A 1-x, 1-y, -z 
O1W—H12W 0.92 (2) 1.93 (2) 160 (2) 2.805 (2) O2W -x, 1-y, -z 
O2W—H21W 0.92 (2) 1.84 (2) 164 (2) 2.741 (2) O1W x, 1+y, z 
O2W—H22W 0.87 (2) 1.87 (2) 171 (2) 2.762 (2) O3A x, y, z 
O3W—H31W 0.90 (2) 2.13 (2) 153 (2) 2.965 (2) O2 1-x, -y, 1-z 
O3W—H32W 0.94 (2) 2.08 (2) 169 (2) 3.004 (2) O1 x, y, z 
CfH2(Hba)∙H2O   (3) 
O2—H2 0.92 (3) 1.63 (4) 156 (3) 2.502 (4) O1 x, y, z 
C1—H01A 0.97 2.25 124 2.902 (4) F x, y, z 
N1—H0A 0.89 1.83 168 2.708 (3) O2A x, y, z 
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N1A—H1A 0.86 2.09 163 2.924 (3) O1A 1-x, 2-y, 1-z 
N1B—H1B 0.86 1.98 173 2.831 (3) O2A -x, 2-y, 1-z 
O1W—H11W 0.94 (3) 1.84 (3) 174 (3) 2.779 (4) O3A x, y, z 
O1W—H12W 0.92 (4) 1.94 (4) 173 (3) 2.859 (4) O2W -x, 1-y, 1-z 
 
 
a) 
 
 
b) 
Figure 1. Schemes of ciprofloxacin (a) and barbituric acids (b): X=O in H2ba and X=S in H2tba. 
 
 
 
a) b) 
 
c) 
 
Fig. 2 The asymmetric part of the unit cell: a) CfH2(Htba)∙3H2O (1); b) CfH2(Hba)(H2ba)∙3H2O 
(2); c) CfH2(Hba)∙H2O (3). Ellipsoids are drawn at the 50% probability level, except for the 
hydrogen atoms represented by spheres. The intramolecular hydrogen bonds are shown with 
dashed lines. 
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a) 
 
b) 
 
c) 
Fig. 3 Hydrogen bonding in 1 (a), 2 (b) and 3 (c). The H-bonds are marked by dashed lines, the 
H-bond motifs are marked by circles and broad lines. Labels A and B in 2 marked Hba– and 
H2ba, respectively. 
 
 
 
